Drug Discovery Research in Aging and Longevity for Indian population.
We meet 2 times (Sat & Sun 3-4pm IST) during weekends for discussions on the stages of drug discovery, research process, how to enter into this field, research possibilities you including failure and success stories.
Previous Sessions
DD: Drug Discovery
S1E0: Intro to DD
S1E1: Role of Biology in DD
S1E2: Stages in DD
S1E3: Target Identification
S1E4: Requirements in DD
S1E5: Mining Drug DB
S1E6: Systems Vaccinology
S1E7: Systems Phenomics
S1E8: Design Research Proposal
S1E9: Jobs in Drug Discovery
S1E10: Why to Network/Collaborate
S1E11: Gene Therapy & Genetic Disorders
S1E12:
Nyro Research India, Cochin
http://nyroindia.org
Podcast : Drug Discovery Research
Focus on Science: No politics, No promotions, No marketing, No followers request other than audience's requests. Focus on Science, Drug Discovery, Aging, Longevity and Upskilling young minds. All rooms monitored.
Intro & Membership: Kindly introduce yourself during club discussions, engage in discussions, respect others perspectives. Membership is invitation and recommendation based. Kindly update your profile Bio in Clubhouse.
Community Building: Nyro Research aims a high quality Drug Discovery, Aging, Longevity community within India. We sincerely welcome scholars, experts, professionals and scientists in the above mentioned domains. Thanks
Focus on Science
No politics, No promotions, No marketing, No followers request other than audience's requests. Focus on Science, Drug Discovery, Aging, Longevity and Upskilling young minds. All rooms monitored.
Intro & Membership
Kindly introduce yourself during club discussions, engage in discussions, respect others perspectives. Membership is invitation and recommendation based. Kindly update your profile Bio in Clubhouse.
Community Building
Nyro Research aims a high quality Drug Discovery, Aging, Longevity community within India. We sincerely welcome scholars, experts, professionals and scientists in the above mentioned domains. Thanks
Day | Members | Gain | % Gain |
---|---|---|---|
June 26, 2024 | 334 | +3 | +1.0% |
March 20, 2024 | 331 | 0 | 0.0% |
January 30, 2024 | 331 | 0 | 0.0% |
December 16, 2023 | 331 | +1 | +0.4% |
November 06, 2023 | 330 | 0 | 0.0% |
October 07, 2023 | 330 | 0 | 0.0% |
September 07, 2023 | 330 | 0 | 0.0% |
August 09, 2023 | 330 | 0 | 0.0% |
July 08, 2023 | 330 | 0 | 0.0% |
June 15, 2023 | 330 | +1 | +0.4% |
March 15, 2023 | 329 | +2 | +0.7% |
February 03, 2023 | 327 | +1 | +0.4% |
December 27, 2022 | 326 | +1 | +0.4% |
September 11, 2022 | 325 | +2 | +0.7% |
September 02, 2022 | 323 | +1 | +0.4% |
August 20, 2022 | 322 | +1 | +0.4% |
July 31, 2022 | 321 | +3 | +1.0% |
July 25, 2022 | 318 | +1 | +0.4% |
July 18, 2022 | 317 | +1 | +0.4% |
July 12, 2022 | 316 | -1 | -0.4% |
June 02, 2022 | 317 | +1 | +0.4% |
May 20, 2022 | 316 | +2 | +0.7% |
May 14, 2022 | 314 | +1 | +0.4% |
April 30, 2022 | 313 | +1 | +0.4% |
April 23, 2022 | 312 | +1 | +0.4% |
April 16, 2022 | 311 | +1 | +0.4% |
April 09, 2022 | 310 | +1 | +0.4% |
April 02, 2022 | 309 | +1 | +0.4% |
March 26, 2022 | 308 | +1 | +0.4% |
March 11, 2022 | 307 | +5 | +1.7% |